SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-021207
Filing Date
2021-11-02
Accepted
2021-11-02 16:41:55
Documents
82
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aqst-20210930.htm   iXBRL 10-Q 1306451
2 EX-31.1 aqst-09302021ex311.htm EX-31.1 11000
3 EX-31.2 aqst-09302021ex312.htm EX-31.2 11207
4 EX-32.1 aqst-09302021ex321.htm EX-32.1 6500
5 EX-32.2 aqst-09302021ex322.htm EX-32.2 6557
  Complete submission text file 0001628280-21-021207.txt   6707699

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20210930.xsd EX-101.SCH 54429
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aqst-20210930_cal.xml EX-101.CAL 60586
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aqst-20210930_def.xml EX-101.DEF 257498
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20210930_lab.xml EX-101.LAB 625135
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20210930_pre.xml EX-101.PRE 415172
11 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20210930_htm.xml XML 1051202
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38599 | Film No.: 211372044
SIC: 2834 Pharmaceutical Preparations